Brainomix and Boehringer Ingelheim will advance testing of an AI-based analysis tool that may enable earlier diagnosis of PF.
Boehringer Ingelheim's alliance with digital health company Brainomix on an AI-enabled tool for diagnosing interstitial lung ...
CT scans can play a role not just in diagnosing but also in monitoring non–cystic fibrosis bronchiectasis management, explained James D. Chalmers, MD. The use of CT scans is moving beyond a simple ...
Transatlantic lung disease powerhouse Brainomix is partnering with German pharma giant Boehringer Ingelheim to improve the ...
The two companies are broadening their partnership, building on strong results seen in the initial phase which demonstrated e-Lung's potential to enable earlier diagnosis of progressive pulmonary ...
Experts representing multiple societies and institutions across 14 countries have published guidance for computed tomography (CT) imaging in patients with residual lung abnormalities after COVID-19 ...
Delays in diagnosis, poor integration among professionals, insufficient local services, and few prescribing centers: these ...
Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in etiology, share a common trajectory of irreversible lung scarring and functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results